Consistent with this idea, checkpoint kinases prevent mitotic catastrophe in doxorubicin-treated cancer cells68, and combinations of the DSB inducer irinotecan and CHK1 inhibitors efficiently eliminate tumour cells69. The gene discussed is CHEK1; the disease is neoplasm.